3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
2
Status
Recruiting
2
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Endocrine
2
CNS
2
Conditions
Brain Neoplasms
12
Meningioma
6
Glioma
6
Glioblastoma
4
Pituitary Neoplasms
2
Pinealoma
2
Oligodendroglioma
2
Gliosarcoma
2
Craniopharyngioma
2
Astrocytoma
2
Prostatic Neoplasms
1
Neuroblastoma
1
Neurilemmoma
1
Nerve Sheath Neoplasms
1
Medulloblastoma
1
Malignant Brain Glioma
1
Hemangiopericytoma
1
Head and Neck Neoplasms
1
Ganglioneuroblastoma
1
Ependymoma
1
Central Nervous System Neoplasms
1
Carcinoma, Non-Small-Cell Lung
1
Carcinoma, Hepatocellular
1
Interventions
Proton Therapy
2
pegvisomant
1
lutetium Lu 177 dotatate
1
entinostat
1
Temozolomide
1
Surveys and Questionnaires
1
Rosiglitazone
1
Radiation Dose Hypofractionation
1
Protons
1
Prednisone
1
Photochemotherapy
1
Octreotide
1
Neuropsychological Tests
1
Microarray Analysis
1
Hydrocortisone
1
Dihematoporphyrin Ether
1
Dexamethasone
1
DNA Methylation
1
Clinical Laboratory Techniques
1
Calcium Dobesilate
1
Cabergoline
1
Blood Specimen Collection
1
Aminolevulinic Acid
1
90Y-octreotide, DOTA-Tyr(3)-
1
2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Pituitary Neoplasms
×
Proton Therapy
×
CNS
×
Clear all
NCT04278118
2026-02-17
HiPPI
Emory University
Phase NA
Recruiting
70 enrolled
NCT06831461
2025-09-16
PRIDE
Tata Memorial Centre
Phase NA
Recruiting
156 enrolled